BREAST CANCER PAIN CONDITIONS AND MEDICATION USE AMONG COMMERCIALLY INSURED BREAST CANCER PATIENTS

被引：0
|
作者：
Lakkad, M. [1 ]
Painter, J. T. [2 ]
机构：
[1] Univ Arkansas Med Sci, Coll Pharm, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN367
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [1] Breast Reconstruction Among Commercially Insured Women With Breast Cancer in the United States
    Barnow, Andrea
    Canfield, Todd
    Liao, Ray
    Yadalam, Sashi
    Kalsekar, Iftekhar
    Khanna, Rahul
    [J]. ANNALS OF PLASTIC SURGERY, 2018, 81 (02) : 220 - 227
  • [2] Adherence to hormonal therapy among commercially insured breast cancer patients.
    Zhao, Hui
    Lei, Xiudong
    Chavez-MacGregor, Mariana
    He, Weiguo
    Niu, Jiangong
    Giordano, Sharon Hermes
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] FACTORS INFLUENCING THE USE OF MASTECTOMY AMONG WOMEN WITH BREAST CANCER IN A COMMERCIALLY INSURED US POPULATION
    Khanna, R.
    Kalsekar, I
    Bamow, A.
    Canfield, T.
    Liao, R.
    Yadalam, S.
    Alderman, A.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A125 - A125
  • [4] Machine learning to predict tamoxifen adherence among US commercially insured breast cancer patients.
    O'Neill, Tyler J.
    Sharma, Vishakha
    Siadimas, Athanasios
    Babaeian, Amir
    Yerrapragada, Gayathri
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [5] Machine Learning to Predict Tamoxifen Nonadherence Among US Commercially Insured Patients With Metastatic Breast Cancer
    Yerrapragada, Gayathri
    Siadimas, Athanasios
    Babaeian, Amir
    Sharma, Vishakha
    O'Neill, Tyler J.
    [J]. JCO CLINICAL CANCER INFORMATICS, 2021, 5 : 814 - 825
  • [6] Disparities in Medical Care Among Commercially Insured Patients With Newly Diagnosed Breast Cancer Opportunities for Intervention
    Short, Louise J.
    Fisher, Maxine D.
    Wahl, Peter M.
    Kelly, Monique B.
    Lawless, Grant D.
    White, Sandra
    Rodriguez, Nancy A.
    Willey, Vincent J.
    Brawley, Otis W.
    [J]. CANCER, 2010, 116 (01) : 193 - 202
  • [7] Patterns of Opioid Use in Commercially Insured Patients With Cancer
    Tham Thi Le
    Fleming, Sean P.
    Simoni-Wastila, Linda
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (05): : 207 - 211
  • [8] THE IMPACT OF GENOMIC TESTING ON CHEMOTHERAPY USE AND MEDICAL SPENDING IN A COMMERCIALLY-INSURED POPULATION OF BREAST CANCER PATIENTS
    Epstein, A. J.
    Wong, Y.
    Mitra, N.
    Vachani, A.
    Hin, S.
    Yang, L.
    Smith-McLallen, A.
    Armstrong, K.
    Groeneveld, P. W.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A217 - A218
  • [9] Complications Associated With Use of Long-Term Central Venous Catheters Among Commercially Insured Women With Breast Cancer
    Lipitz-Snyderman, Allison
    Ma, Qinli
    Pollack, Michael F.
    Barron, John
    Elkin, Elena B.
    Bach, Peter B.
    Malin, Jennifer L.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2015, 11 (06) : 505 - +
  • [10] Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
    Sedjo, Rebecca L.
    Devine, Scott
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) : 191 - 200
12345